X

Drug Profile

Tinoridine

Alternative Names: Nonflamin; Tienoridine; Tienoridine hydrochloride; Tinoridine hydrochloride; Y 3642

Latest Information Update: 01 Oct 2007

Price : $50 ^*

Adis is an information provider. We do not sell or distribute actual drugs.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

Originator Mitsubishi Pharma Corporation
Developer Mitsubishi Tanabe Pharma Corporation
Class Analgesics; Nonsteroidal anti-inflammatories; Pyridines
Mechanism of Action Cyclooxygenase inhibitors

Orphan Drug Status

Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

No

Highest Development Phases

Marketed Inflammation; Pain

Most Recent Events

01 Oct 2007 Mitsubishi Pharma Corporation has merged with Tanabe Seiyaku to form Mitsubishi Tanabe Pharma Corporation
06 Apr 2000 Yoshitomi is now called Welfide Corporation
16 Feb 1998 New profile

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com